AND File No. RD (NWR)/441/035/2023/ 292F SRN GNL-1 F61964771Dated: 19.06.2023 BEFORE THE REGIONAL DIRECTOR (NWR), AHMEDABAD MINISTRY OF CORPORATE AFFAIRS IN THE MATTER OF :- SECTION 441 OF THE COMPANIES ACT, 2013 SECTION 177 OF THE COMPANIES ACT, 2013 IN THE MATTER OF :-

1. Sun Pharmaceutical Industries Limited

Dilip Sanghvi -(Applicant No.1) -(Applicant No.2) FINAL ORDER pateii 0 OCT 204

1. Compounding application received from: . Sun Pharmaceutical Industries Limited i}
2. Dilip Sanghvi
3. Shailesh Desai, WTD 4, Sudhir Valia, WTD
4. K. Subramanian, WTD -(Applicant No.1) -(Applicant No.2) -(Applicant No.3) -(Applicant No.4) -(Applicant No.5) under Section 441 of the Companies Act, 2013.
5. Violation-Details and nature of the violation: Not taking omnibus approval of Audit Committee as well as Board of Directors of the company while entering the related party transaction during the financial years 2014-15 to 2017-18. w
6. Compounding fee levied: Reference of interim order: No. RD(NWR)/441/035/2023/2342 dated 29.08.2024. Sr. | Named Designation of the Provision violated for | Compounding fee No. | Applicant the year. payable by the applicant (In Rs.)
7. | Sun Pharmaceutical Industries 2014-151t02017-18 4,80,000/- Limited
8. | Dilip Sanghvi, MD 2014-15t0 2017-18 1,20,000
9. | Shailesh Desai, WTD 2014-15t02017-18 1,20,000
10. | Sudhir Valia, WTD 2014-15t02017-18 1,20,000
11. | K. Subramanian, WTD 2014-15t0 2017-18 1,20,000 Total 9,60,000/+/
12. Payment of Compounding fee: (\Ko Sr. | Name and Designation of the | Receipt details Amount paid No. | Applicant (In Rs.)

Sun Pharmaceutical Industries X81736571 Dated 05.09.2024 4,80,000/- Limited 2, Dilip Sanghvi, MD X81739245 Dated 05.09.2024 1,20,000 3. Shailesh Desai, WTD X81739286 Dated 05.09.2024 1,20,000 4. Sudhir Valia, WTD X81739203 Dated 05.09.2024 1,20,000 5. K. Subramanian, WTD X81739559 Dated 05.09.2024 1,20,000 Total 9,60,000/- | 6. Considering the facts and circumstances described in interim order dated 29.08.2024 and payment of compounding fee, the compounding application bearing SRN F61964771 (GNL-1) is hereby allowed. l|Page

| A 7. Company is hereby directed to file this compounding order in prescribed E-form INC-28 with the jurisdictional ROC under the provisions of Section 441(3)(d) of the Companies Act, 2013. Dated this [gn:lay of October, 2024 (G. C. YADAV) Regional Director (NWR)(I/C) Ahmedabad To )Aun Pharmaceutical Industries Limited SPARC, Tandalja, Vadodara, Gujarat-390012. . Dilip Sanghvi Tirth, New India Society No. 17, 12" Road, JVPD, Vile Parle West, Mumbai, Maharashtra - 400049. . Shailesh Desai Aditya A Wing, 10" FLR, Gulmohor X RD No. 7 JVPD Scheme, Vile Parle West, Mumbai, Maharashtra - 400049 . Sudhir Valia 801, 8" Floor, Aalap Building, 173 Sir Bhalchandra Road, Opp. Hindu Colony, Dadar(East), Mumbai, Maharashtra - 400014. . K. Subramanian No. 7, FL No A2, 2™ Floor, Regency Liguori Walton Road, Banglore, Karnataka 560001. . Registrar of Companies, Ahmedabad, Gujarat . Master File . Office Copy

(Kamal Harjani) Joint Director For Regional Director 2|Page